180 results
Page 2 of 9
8-K
EX-99.1
w1erzmw26k4 m4
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
EX-99.1
23f48pnz8
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
EX-99.1
vfgg8xv0oq
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
8-K
EX-99.1
tlik 3ody
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
EX-99.1
986r9uk6vf
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm
8-K/A
EX-99.1
fgfm c2knekgi67guy
8 Mar 19
Completion of Acquisition or Disposition of Assets
4:24pm
8-K/A
EX-99.2
x7riljfww1
8 Mar 19
Completion of Acquisition or Disposition of Assets
4:24pm
8-K
EX-99.1
h2j8e3yqxfzwcip
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
EX-99.1
gluw fjvh3xewfyhhj7
24 Jul 18
Windtree Announces Completion of New Design Development for its Aerosol Delivery System (ADS) including Successful Performance Testing
5:01pm
8-K
EX-99.1
ylh19l
18 Apr 16
Amendments to Articles of Incorporation or Bylaws
12:00am
424B5
tp4jbjc
21 Jul 15
Prospectus supplement for primary offering
12:00am